• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

Introduction to 2,4(1H,3H)-Pyrimidinedione,5-(dimethylamino) (CAS No. 37454-51-6) and Its Emerging Applications in Chemical Biology

The compound 2,4(1H,3H)-Pyrimidinedione,5-(dimethylamino), identified by the CAS number 37454-51-6, represents a significant molecule of interest in the realm of chemical biology and pharmaceutical research. This heterocyclic compound, featuring a pyrimidine core with distinct functional groups, has garnered attention due to its structural versatility and potential biological activities. The presence of a 5-(dimethylamino) substituent and the inherent reactivity of the 2,4(1H,3H)-pyrimidinedione moiety make this compound a valuable scaffold for the development of novel therapeutic agents.

Recent advancements in medicinal chemistry have highlighted the importance of pyrimidine derivatives in drug discovery. Pyrimidines are fundamental components of nucleic acids and play a crucial role in various biological processes. The structural framework of 2,4(1H,3H)-Pyrimidinedione,5-(dimethylamino) allows for modifications that can fine-tune its interactions with biological targets. This flexibility has been exploited in the design of molecules targeting enzymes and receptors involved in diseases such as cancer, inflammation, and infectious disorders.

In particular, the 5-(dimethylamino) group introduces basicity to the molecule, which can be leveraged to enhance binding affinity to acidic or negatively charged residues on protein targets. This feature has been particularly useful in the development of small-molecule inhibitors. Studies have demonstrated that compounds incorporating this moiety exhibit promising activity against various enzymes implicated in disease pathways. For instance, modifications to the pyrimidine core have led to the discovery of inhibitors with potential applications in oncology.

One area where this compound has shown significant promise is in the inhibition of kinases—enzymes that play a pivotal role in cell signaling pathways. Aberrant kinase activity is often associated with tumor growth and progression. Researchers have synthesized derivatives of 2,4(1H,3H)-Pyrimidinedione,5-(dimethylamino) that exhibit kinase inhibitory properties. These derivatives have been tested in vitro and in vivo, demonstrating efficacy in preclinical models. The ability to modulate kinase activity makes this compound a compelling candidate for further development into therapeutic agents.

The synthesis of 2,4(1H,3H)-Pyrimidinedione,5-(dimethylamino) involves multi-step organic reactions that highlight its synthetic accessibility. The 2,4(1H,3H)-pyrimidinedione core can be synthesized through condensation reactions between appropriate precursors under controlled conditions. The introduction of the 5-(dimethylamino) group typically follows via nucleophilic substitution or other functionalization strategies. These synthetic routes have been optimized to ensure high yields and purity, making it feasible for large-scale production required for further research and development.

From a computational chemistry perspective, molecular modeling studies have been instrumental in understanding the binding interactions of 2,4(1H,3H)-Pyrimidinedione,5-(dimethylamino) with biological targets. These studies provide insights into how structural modifications can enhance potency and selectivity. For example, computational analysis has revealed that subtle changes to the pyrimidine ring can significantly alter binding affinity to proteins such as kinases or transcription factors. This information is crucial for guiding the design of next-generation analogs with improved pharmacological profiles.

The compound's potential extends beyond its kinase inhibitory properties. Researchers are exploring its utility as a tool compound in biochemical assays designed to investigate enzyme mechanisms and substrate recognition. By serving as a reference point or inhibitor in these assays, 2,4(1H,3H)-Pyrimidinedione,5-(dimethylamino) aids in elucidating complex biological pathways and identifying new therapeutic targets.

In conclusion,2,4(1H,3H)-Pyrimidinedione,5(dimethylamino) (CAS No. 37454-51-6) stands as a versatile molecule with significant implications for chemical biology and drug discovery. Its unique structural features and demonstrated biological activities make it a valuable asset for researchers aiming to develop novel therapeutics against various diseases. As ongoing studies continue to uncover new applications and refine synthetic methodologies,this compound is poised to remain at the forefront of pharmaceutical innovation.

• 7577-92-6(5-Methylaminouracil)
• 89533-45-9(urea, 1-methyl-3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-)
• 88801-18-7(2,4-Imidazolidinedione, 5-[(dimethylamino)methylene]-3-methyl-, (Z)-)
• 16952-91-3(Acetamide,N-(1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-)
• 56012-71-6(Urea,N-methyl-N'-(1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-)
• 7504-26-9( )
• 55476-36-3(2,4(1H,3H)-Pyrimidinedione,5-(diethylamino)-)
• 23899-79-8(5-amino-1-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione)
• 497232-84-5(2,4-Imidazolidinedione, 5-[(dimethylamino)methylene]-1,3-dimethyl-,(5Z)-)
• 497232-85-6(2,4-Imidazolidinedione, 5-[(dimethylamino)methylene]-1-methyl-, (5Z)-)